Accuracy of Continuous and Non-invasive Hemoglobin Monitoring

Accuracy of Continuous and Non-invasive Hemoglobin Monitoring During Laparoscopic Gastrectomy: Observational Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03957460

Enrollment

Registered

2019-05-21

Start date

2017-11-20

Completion date

2017-12-29

Last updated

2021-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Brief summary

The primary purpose of this observational study is to investigate the accuracy on the continuous and non-invasive hemoglobin monitoring during laparoscopic gastrectomy.

Interventions

OTHERSpHb monitoring

Subjects receive the continuous and noninvasive hemoglobin monitoring (SpHb monitoring).

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

19 Years to 85 Years

Healthy volunteers

Inclusion criteria

* laparoscopic gastrectomy under general anesthesia

Exclusion criteria

* atypical hemoglobin disease, infective state, cardiovascular disease, peripheral vascular disease

Design outcomes

Primary

Measure	Time frame	Description
difference between SpHb value in g/dL and SaHb value in g/dL (SpHb - SaHb)	from the start of anesthesia to the end of anesthesia, an average 2 hours	SpHb value in g/dL is measured by co-oxymetry, and SaHb value in g/dL is measured by blood sampling.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026